MicroRNA-based assay for differential diagnosis of mesothelioma
Dalia Cohen(Regulus Therapeutics (United States)), Danit Lebanony(Rosetta Genomics (Israel)), Shai Rosenwald(Rosetta Genomics (Israel)), Hadas Gibori(Tel Aviv University), Naama Barabash(Rosetta Genomics (Israel)), Eti Meiri(Rosetta Genomics (Israel)), Sarit Tabak(Rosetta Genomics (Israel)), Sara Morgenstern(Tel Aviv University), Zvi Bentwich(Ben-Gurion University of the Negev)
Cited by 1
Related Papers
MicroRNAs accurately identify cancer tissue origin
|Nature Biotechnology|2008|987
Diagnostic Assay Based on hsa-miR-205 Expression Distinguishes Squamous From Nonsquamous Non–Small-Cell Lung Carcinoma
|Journal of Clinical Oncology|2009|410
Histone Deacetylase Inhibition Selectively Alters the Activity and Expression of Cell Cycle Proteins Leading to Specific Chromatin Acetylation and Antiproliferative Effects
|Journal of Biological Chemistry|1999|393
Design of a genome-wide siRNA library using an artificial neural network
|Nature Biotechnology|2005|386
Identification of a family of cAMP response element-binding protein coactivators by genome-scale functional analysis in mammalian cells
|Proceedings of the National Academy of Sciences|2003|374